October 26, 20268 min readADHD and focus

Is It ADHD, PMDD, or Both Before Your Period?

Women with ADHD screen positive for PMDD far more often in survey data. See what the research can and cannot say, and how to track two cycles.

Rachel Stein

Last reviewed: October 2026

A worried yellow buddy in glasses stands bracing on a moonlit beach while a tall wave rises on its left and calm flat sea stretches away on its right.

ADHD PMDD overlap is common in survey data, but only daily tracking over two cycles can confirm PMDD. In a 2025 survey of 715 women, PMDD-like symptoms appeared in 31.4% to 41.1% of women with ADHD and 9.8% of women without. If your focus and mood collapse before your period, you may have PMDD, an ADHD flare, or both.

The evidence is thin. It rests on one survey that screens by recall, a few small cycle studies, and a case series of nine women.

What is ADHD PMDD, and are the two connected?

ADHD PMDD is shorthand for having both conditions, or for ADHD symptoms that rise and fall with PMDD-like mood changes. PMDD is a diagnosis that needs at least five of 11 listed symptoms during the luteal phase, the second half of the cycle, and it excludes a worsening of another psychiatric disorder, according to Reilly and colleagues' 2022 meta-analysis in the Journal of Psychopharmacology. A 2022 scoping review by Carlini and colleagues in the International Journal of Women's Health reports a DSM-5 12-month prevalence of 1.8% to 5.8% among menstruating women in the US.

If you were diagnosed with ADHD as an adult, why ADHD in women gets missed for decades may explain why the monthly pattern went unlinked.

Do women with ADHD have a higher risk of PMDD?

Survey data say yes. In a 2025 cross-sectional online survey in the British Journal of Psychiatry, Agnew-Blais and colleagues recruited 715 UK women aged 18 to 34 through the Prolific platform. In the sample, 102 reported a clinician diagnosis of ADHD, 229 met symptom-scale criteria for ADHD (the groups overlap), and 305 formed a non-ADHD comparison group.

Provisional PMDD, measured with a screening questionnaire, appeared in 31.4% of the self-reported diagnosis group, 41.1% of the scale-based group and 9.8% of the comparison group. That is a 3.19-fold and a 4.17-fold higher risk. The highest risk was in women with ADHD plus depression or anxiety (relative risk 4.53, 95% CI 3.10 to 6.61, in the scale-based group).

The limits are large. The questionnaire relies on recall, which the authors say is linked to false positives compared with daily ratings. The study could not separate PMDD from a premenstrual worsening of ADHD, depression or anxiety, and it over-recruited women with ADHD, so the percentages do not describe all women. It shows an association between the two. Take it as a good reason to start tracking.

Why does ADHD get worse before my period?

Nobody has proven why. A 2025 systematic review in the Journal of Attention Disorders by Gurvich and colleagues found 11 studies on ADHD and sex hormones in females, and only 6 enrolled people with an ADHD diagnosis. Four of the 11 were rated unsatisfactory for risk of bias. The authors called the evidence "largely suggestive" of a link between symptoms and hormones across the cycle.

Roberts and colleagues (2018) followed women prospectively across the cycle. In women with high trait impulsivity, low estradiol predicted worse ADHD symptoms in the context of high progesterone or testosterone environments, and the early luteal phase was the main period of worsening. A small interview study of 10 women by Bürger and colleagues described worse inattention and executive function in the mid-luteal phase and during menses.

The leading explanation is a hypothesis. In preclinical studies, estrogen has been shown to stimulate dopamine production and reduce its reuptake and breakdown, so the premenstrual drop in estrogen could leave less dopamine available. Agnew-Blais and colleagues raise this idea, and Gurvich and colleagues describe it as preclinical. It has not been tested directly in women with ADHD in these sources, so let your own two-cycle record, described below, show what fits you.

What is the difference between PMDD and premenstrual exacerbation of ADHD?

PMDD is its own diagnosis, and premenstrual exacerbation is an existing condition that gets louder before your period. The definition Reilly and colleagues quote excludes exacerbation of another disorder. Carlini and colleagues note that international consensus guidelines list premenstrual exacerbations of underlying psychiatric disorders as a separate "variant" category.

Agnew-Blais and colleagues point to one feature that separates them, a symptom-free window after your period starts. PMDD symptoms are expected to fade after menses begin. ADHD symptoms that are present all month and get louder before your period would be the pattern you take to a clinician as possible exacerbation. You can have both, and a clinician makes the call.

Your own record will show which category fits you better than any statistic.

Do ADHD meds work less in the week before my period?

Some women report that, and the research is early. Wynchank and Kooij, in a narrative review in Drugs & Aging, say stimulants "may be" less effective when estrogen is low, such as the luteal phase, and that randomised trial data are lacking. A 2020 expert consensus statement led by Young in BMC Psychiatry says the evidence does not support adjusting treatment by cycle, though clinicians described anecdotal benefit.

The one clinical report is a case series by de Jong, Kooij and colleagues in Frontiers in Psychiatry (2023). It followed 9 consecutive women aged 22 to 48 at an adult ADHD clinic in the Netherlands, six of whom had a PMDD diagnosis. After a prescriber raised the psychostimulant dose in the premenstrual week, all nine reported better ADHD and mood symptoms, and all chose to continue.

The authors state that they describe "a very small number of patients" and "lack a control group," and they call for randomised, double-blind trials. Treat this as a conversation starter, since prescribers set each change individually and a dose is never yours to adjust alone. Bring your symptom record and ask what your prescriber would try.

Do SSRIs help PMDD, and can you take them only in the second half of the cycle?

SSRIs have the strongest evidence for PMDD, and taking them only in the luteal phase is an accepted schedule. The Carlini scoping review of 194 studies found the best-quality evidence for SSRIs and combined oral contraceptives, and reports that expert guidelines treat SSRIs, dosed continuously or only in the luteal phase, as the gold standard for PMDD. In a Phase III trial of a 24-active, 4-placebo-day pill with ethinyl estradiol and drospirenone, symptoms dropped most after 3 months. The review also notes placebo responses in the PMS literature as high as 50% in some studies.

On the schedule question, Reilly and colleagues pooled 8 randomised trials with 460 participants, 212 on intermittent dosing and 248 on continuous. They found no significant difference in response (odds ratio 1.0, 95% CI 0.23 to 4.31), dropout (odds ratio 1.26) or symptom change (standardised mean difference 0.04). No trial was rated low risk of bias, four were rated high, and the response result varied a lot between trials.

Neither review tested women with ADHD, so ask a prescriber how these options fit alongside any ADHD medication you take.

Is it ADHD, PMDD, or perimenopause when my mood and focus swing?

It can be any of them, and your calendar helps sort it out. Agnew-Blais and colleagues suggest the extra risk in women with ADHD may not be specific to PMDD and may reflect sensitivity to ovarian hormone shifts more broadly, including puberty, pregnancy, perimenopause and menopause. Young and colleagues' consensus statement says ADHD symptoms may be exacerbated by hormonal changes across the menstrual cycle, pregnancy and menopause.

A monthly rhythm that clears after your period points toward the cycle. A pattern that follows a stage of life, with changing periods, is worth raising with your clinician. Our guides on ADHD and perimenopause and ADHD and menopause cover those stages. If the intensity of your reactions is the main problem all month, ADHD and emotional regulation covers that.

What can I do at work or home during the hard premenstrual days?

Plan around the days your record shows. None of these steps was tested in the studies above, and each is built on your own data.

Mark the window. Put your usual hard days on your calendar once two cycles of notes show a pattern.

Front-load what you can. Move deadlines and tasks that need long focus away from that window when your schedule allows.

Lower the cost of starting. Write the first step of each task down ahead of time, and put reminders and routines in writing before the window opens.

Tell one person. Choose someone who can check in on those days. A buddy on GetMotivated.ai can be that person, someone who checks in on whether you logged today.

For treatment options beyond planning, ADHD in women: evidence-based treatment paths is the place to start.

How do I track symptoms to tell ADHD, PMS and PMDD apart?

Track every day for two cycles. Carlini and colleagues say PMDD is established by two months of prospective daily monitoring, before treatment begins, with a validated tool such as the Daily Record of Severity of Problems. They add that retrospective screens have limited value because of recall bias.

Step 1. Ask a clinician for the Daily Record of Severity of Problems, or use any daily log that captures the same things.

Step 2. Each evening, rate focus, starting tasks, irritability, low mood and sleep on a 1 to 5 scale.

Step 3. Mark day 1 of bleeding each cycle.

Step 4. Look for a symptom-free stretch after your period starts, and note whether ADHD symptoms stay high all month.

Step 5. Bring the record to a clinician who knows both ADHD and premenstrual disorders. Ask whether your pattern looks like PMDD, an exacerbation, or both.

A clinician makes the diagnosis, and your record is the evidence to bring. In the US, call or text 988 (Suicide & Crisis Lifeline) if you are thinking about hurting yourself.

Start tonight. Write down today's date, rate your focus and mood from 1 to 5, set a daily alarm for the same time tomorrow, and keep logging until you have two full cycles to show.

Next time you search, our newest guide shows up.

Sources

Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey studyResearch
Broughton T et al.
BackgroundDue to historical under-recognition of attention-deficit hyperactivity disorder (ADHD) among girls and women, little is known about female-specific factors that may affect individuals with ADHD, including those related to changes in ovarian hormones (e.g. across the menstrual cycle).AimsWe investigated whether females with a self-reported clinical diagnosis of ADHD are more likely to experience premenstrual dysphoric disorder (PMDD). We also examined associations between PMDD and ADHD defined by a symptom and impairment threshold.MethodParticipants were aged between 18 and 34 years, were assigned female at birth and were recruited via Prolific.com (n = 715). Participants self-reported clinician diagnosis of ADHD, depression and anxiety. ADHD symptoms were assessed via the Adult ADHD Self-Report Scale (ASRS), to which we applied a DSM-5-based symptom and impairment cut-off ('ASR
ADHD and Sex Hormones in Females: A Systematic ReviewResearch
Osianlis E et al.
ObjectiveADHD is a neurodevelopmental condition associated with elevated symptoms of inattention and hyperactivity/impulsivity. Symptoms of ADHD typically persist into adulthood and can impair functioning and overall quality of life. In females (including women and people assigned female at birth), ADHD is under-recognized, and knowledge about the relationship between ADHD symptoms and sex hormones is lacking. This systematic review aimed to synthesize the current evidence investigating the relationship between ADHD symptoms (including medication effects) and sex hormones in females.MethodSearches were conducted within Ovid MEDLINE, Embase, and PsycINFO from 1980 to January 2025. Included studies investigated ADHD symptoms in the context of hormonal changes in females, including studies specifically exploring ADHD and sex hormones, as well as hormonal life stages (puberty, menstrual cycl
Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosageResearch
de Jong M et al.
ObjectiveAttention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental condition which is underdiagnosed and undertreated in women. For decades, the ADHD field has called for more insight into female-specific therapy. Preliminary findings postulate that changes in sex hormones during the menstrual cycle may influence the effectiveness of psychostimulant medication. Yet, pharmacotherapeutic interventions tailored to women with ADHD remain scarce. Previously, our group showed an increase in mood symptoms in the premenstrual week in women with ADHD. Premenstrual worsening of depressive and ADHD symptoms represent a treatment challenge. In our adult ADHD clinic, we noted several women describing exacerbation of their ADHD and depressive symptoms in the premenstrual week and/or insufficient effect of their established dosage of psychostimulant. We responded to the need expres
Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trialsResearch
Reilly TJ et al.
BackgroundIntermittent (luteal phase) dosing of selective serotonin reuptake inhibitors is one treatment strategy for premenstrual syndromes such as premenstrual dysphoric disorder. This avoids the risk of the antidepressant withdrawal syndrome associated with long-term continuous dosing.AimsTo compare intermittent dosing to continuous dosing in terms of efficacy and acceptability.MethodsWe searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, PsycINFO, PubMed and CINAHL for randomised trials of intermittent compared with continuous dosing of selective serotonin reuptake inhibitors in premenstrual syndromes. We extracted response rates, dropout rates and changes in symptom scores. We used random effects meta-analyses to pool study-level data and calculated odds ratio for dichotomous data and standardised mean difference for continuous data. Risk of bias was assess
Management of Premenstrual Dysphoric Disorder: A Scoping ReviewResearch
Carlini SV et al.
Premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) refer to physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with menses. The present work is a clinically focused scoping review of the last twenty years of research on treatment for these disorders. A search of key terms using the PubMed/Medline, the Cochrane Library, Embase, and Web of Science databases was performed, and 194 studies of adult women met initial inclusion criteria for review. Research studies concerning medications, pharmacological and non-pharmacological complementary and alternative medicine treatments, and surgical interventions with the most available evidence were appraised and summarized. The most high-quality evidence can be found for the use of selective serotonin reuptake inhibitors (SSRIs) and combined oral contraceptives (COCs), with gonadotropin releas
Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and womenResearch
Young S et al.
Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-MenopauseResearch
Wynchank D & Kooij S.

Topics

AI-ready summary

A 2025 survey of 715 UK women found symptoms consistent with PMDD in 31.4% to 41.1% of women with ADHD, versus 9.8% of women without ADHD. The survey used a recall-based screen, and PMDD is diagnosed only after two months of prospective daily tracking. The estrogen and dopamine explanation is a hypothesis, and medication timing is supported only by a nine-person case series.

Key takeaways

  • A 2025 survey of 715 women found provisional PMDD in 31.4% to 41.1% of women with ADHD and 9.8% of women without, but a recall-based screen cannot confirm PMDD.
  • PMDD is diagnosed with two months of daily prospective symptom tracking, and a clinician must separate it from a premenstrual exacerbation of ADHD.
  • The idea that falling estrogen lowers dopamine and worsens ADHD is a hypothesis built mostly on preclinical work.
  • A premenstrual stimulant increase helped 9 women in an uncontrolled case series, so any dose change is a prescriber decision.
  • Track focus, mood and the first day of your period every day for two cycles, then bring the record to a clinician.

FAQs

What is ADHD PMDD, and are the two connected?

ADHD PMDD means having ADHD and premenstrual dysphoric disorder together, or ADHD symptoms that flare with PMDD-like mood changes. In a 2025 survey of 715 women, symptoms consistent with PMDD appeared in 31.4% to 41.1% of women with ADHD and 9.8% of women without, but a survey screen cannot confirm PMDD.

Do women with ADHD have a higher risk of PMDD?

Survey data say yes, with a 3.19-fold to 4.17-fold higher risk of provisional PMDD in women with ADHD. The survey was cross-sectional and used a recall-based screen, so it shows an association and cannot confirm PMDD in any one person.

Why does ADHD get worse before my period?

No one knows yet. One hypothesis is that falling estrogen lowers dopamine availability, based on animal studies, and a prospective cycle study found worse symptoms when estradiol was low in women with high trait impulsivity, in the context of high progesterone or testosterone. The evidence is early and small.

How is PMDD diagnosed if I have ADHD?

PMDD is established by two months of prospective daily symptom monitoring before treatment starts, using a validated tool such as the Daily Record of Severity of Problems. A clinician also has to decide whether your symptoms are PMDD or a premenstrual exacerbation of ADHD.

Do SSRIs help PMDD, and can you take them only in the second half of the cycle?

Expert guidelines treat SSRIs as the gold standard for PMDD, dosed continuously or only in the luteal phase. A meta-analysis of 8 trials with 460 participants found no significant difference between the two schedules, though every trial had some concerns or high risk of bias.

Can my prescriber raise my ADHD medication dose before my period?

Some prescribers do this, but the only evidence is a case series of 9 women with no control group. Dose changes are a prescriber decision, so bring your symptom record to your appointment and do not adjust medication yourself.

Keep reading